What do you investigate? GWASs in autoimmune and metabolic disorders.
What did you want to be as a kid? An astronaut.
When did you become interested in a career in science? After graduating from college.
What is your favorite thing about Madison? Beautiful and comfortable summer.
What are your hobbies? Basketball, reading, cooking.
What do you like to cook? Different kinds of Chinese food.
Publications
- H Zhang, P Dong, H Fan, H Liang, K Zhang, Y Zhao, S Guo, SJ Schrodi; Y Fan; D Zhang. (2023) Gene body hypomethylation of pyroptosis-related genes NLRP7, NLRP2, and NLRP3 facilitate non-invasive surveillance of hepatocellular carcinoma. Functional & Integrative Genomics. 23 (2), 198.
- X Li, H Fan, X Song, B Song, W Liu, R Dong, H Zhang, S Guo, H Liang, SJ Schrodi, X Fu, S Kaushal, Y Ren, D Zhang. (2023) DNA methylome and transcriptome profiling reveal key electrophysiology and immune dysregulation in hypertrophic cardiomyopathy. Epigenetics. 18 (1), 2195307.
- H Liang, JC Sedillo, SJ Schrodi, A Ikeda. (2022) Structural Variants in Linkage Disequilibrium with GWAS-Significant SNPs. medRxiv. 2022.12.14.22283482.
- H Liang, X Zhang, Z Ma, Y Sun, C Shu, Y Zhu, Y Zhang, S Hu, X Fu, L Liu. (2021) Association of CYP3A5 Gene Polymorphisms and Amlodipine-Induced Peripheral Edema in Chinese Han Patients with Essential Hypertension. Pharmacogenomics and Personalized Medicine. 14: 189-197.
- Y Sun, H Wang, H Liang, Y Yuan, C Shu, Y Zhang, Y Zhu, M Yu, S Hu, N Sun. (2021) A Method for Estimating 24-hour Urinary Sodium Excretion by Casual Urine Specimen in Chinese Hypertensive Patients. American Journal of Hypertension. 34 (7), 718-728.
- C Chen, Y Sun, H Liang, D Yu, S Hu. (2017) A meta-analysis of the association of CKM gene rs8111989 polymorphism with sport performance. Biology of sport. 34 (4), 323-330.
- C Cui, C Shu, D Cao, Y Yang, J Liu, S Shi, Z Shao, N Wang, T Yang, H Liang, S Zou, S Hu. (2016) UGT1A1*6, UGT1A7*3 and UGT1A9*1b polymorphisms are predictive markers for severe toxicity in patients with metastatic gastrointestinal cancer treated with irinotecan-based regimens. Oncology Letters. 12 (5), 4231-4237.